Intra-articular injections of triamcinolone hexacetonide in rheumatoid arthritis : short and long-term improvement predictors
Copyright © 2014 Elsevier Editora Ltda. All rights reserved..
OBJECTIVES: Identify good response predictors to intra-articular injection (IAI) with triamcinolone hexacetonide (TH).
METHODS: This study was carried out in rheumatoid arthritis (RA) patients (American College of Rheumatology criteria) submitted to IAI (mono, pauci or polyarticular injection).
ASSESSMENT: A "blinded" observer prospectively evaluated joints at one week (T1), four weeks (T4), twelve weeks (T12) and 24 weeks (T24) after IAI. Outcome measurements included Visual Analogue Scale (0-10 cm) at rest, in movement and for swollen joints. Clinical, demographic and variables related to injection at baseline were analyzed according to IAI response.
RESULTS: We studied 289 patients with RA (635 joints) with a mean age of 48.7 years (±10.68), 48.5% of them Caucasians, VAS for global pain=6.52 (±1.73). Under univariate analysis, the variables relating the best responses following IAI (improvement > 70%) were: "elbow and metacarpophalangeal (MCP) IAI, and functional class II". Under multivariate analysis, "males" and "non-whites" were the predictors with the best response to IAI at T4, while "elbow and MCP IAI", "polyarticular injection", "use of methotrexate" and "higher total dose of TH" obtained the best response at T24.
CONCLUSION: Several predictors of good response to IAI in patients with RA were identified. The best-response predictors for TH IAI of long term were "apply elbow and MCP IAI" and "apply polyarticular injection".
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:55 |
|---|---|
| Enthalten in: |
Revista brasileira de reumatologia - 55(2015), 3 vom: 06. Mai, Seite 216-22 |
| Sprache: |
Portugiesisch |
|---|
| Weiterer Titel: |
Infiltrações intra-articulares de triancinolona hexacetonida na artrite reumatóide: preditores de melhora a curto e longo prazo |
|---|
| Beteiligte Personen: |
Furtado, Rita Nely Vilar [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 03.05.2017 Date Revised 03.05.2017 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.rbr.2014.08.017 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM244335516 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM244335516 | ||
| 003 | DE-627 | ||
| 005 | 20231224134500.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2015 xx |||||o 00| ||por c | ||
| 024 | 7 | |a 10.1016/j.rbr.2014.08.017 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0814.xml |
| 035 | |a (DE-627)NLM244335516 | ||
| 035 | |a (NLM)25480531 | ||
| 035 | |a (PII)S0482-5004(14)00219-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a por | ||
| 100 | 1 | |a Furtado, Rita Nely Vilar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Intra-articular injections of triamcinolone hexacetonide in rheumatoid arthritis |b short and long-term improvement predictors |
| 246 | 3 | 3 | |a Infiltrações intra-articulares de triancinolona hexacetonida na artrite reumatóide: preditores de melhora a curto e longo prazo |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.05.2017 | ||
| 500 | |a Date Revised 03.05.2017 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2014 Elsevier Editora Ltda. All rights reserved. | ||
| 520 | |a OBJECTIVES: Identify good response predictors to intra-articular injection (IAI) with triamcinolone hexacetonide (TH) | ||
| 520 | |a METHODS: This study was carried out in rheumatoid arthritis (RA) patients (American College of Rheumatology criteria) submitted to IAI (mono, pauci or polyarticular injection) | ||
| 520 | |a ASSESSMENT: A "blinded" observer prospectively evaluated joints at one week (T1), four weeks (T4), twelve weeks (T12) and 24 weeks (T24) after IAI. Outcome measurements included Visual Analogue Scale (0-10 cm) at rest, in movement and for swollen joints. Clinical, demographic and variables related to injection at baseline were analyzed according to IAI response | ||
| 520 | |a RESULTS: We studied 289 patients with RA (635 joints) with a mean age of 48.7 years (±10.68), 48.5% of them Caucasians, VAS for global pain=6.52 (±1.73). Under univariate analysis, the variables relating the best responses following IAI (improvement > 70%) were: "elbow and metacarpophalangeal (MCP) IAI, and functional class II". Under multivariate analysis, "males" and "non-whites" were the predictors with the best response to IAI at T4, while "elbow and MCP IAI", "polyarticular injection", "use of methotrexate" and "higher total dose of TH" obtained the best response at T24 | ||
| 520 | |a CONCLUSION: Several predictors of good response to IAI in patients with RA were identified. The best-response predictors for TH IAI of long term were "apply elbow and MCP IAI" and "apply polyarticular injection" | ||
| 650 | 4 | |a Comparative Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Arthritis rheumatoid | |
| 650 | 4 | |a Artrite reumatoide | |
| 650 | 4 | |a Infiltração | |
| 650 | 4 | |a Injection | |
| 650 | 4 | |a Predictions | |
| 650 | 4 | |a Prognósticos | |
| 650 | 4 | |a Triamcinolone hexacetonide | |
| 650 | 4 | |a Triancinolona hexacetonida | |
| 650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
| 650 | 7 | |a Triamcinolone Acetonide |2 NLM | |
| 650 | 7 | |a F446C597KA |2 NLM | |
| 650 | 7 | |a triamcinolone hexacetonide |2 NLM | |
| 650 | 7 | |a I7GT1U99Y9 |2 NLM | |
| 700 | 1 | |a Machado, Flavia Soares |e verfasserin |4 aut | |
| 700 | 1 | |a Luz, Karine Rodrigues da |e verfasserin |4 aut | |
| 700 | 1 | |a Santos, Marla Francisca dos |e verfasserin |4 aut | |
| 700 | 1 | |a Konai, Monique Sayuri |e verfasserin |4 aut | |
| 700 | 1 | |a Lopes, Roberta Vilela |e verfasserin |4 aut | |
| 700 | 1 | |a Natour, Jamil |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista brasileira de reumatologia |d 2004 |g 55(2015), 3 vom: 06. Mai, Seite 216-22 |w (DE-627)NLM204046807 |x 1809-4570 |7 nnns |
| 773 | 1 | 8 | |g volume:55 |g year:2015 |g number:3 |g day:06 |g month:05 |g pages:216-22 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.rbr.2014.08.017 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 55 |j 2015 |e 3 |b 06 |c 05 |h 216-22 | ||